MARSHALL WACE, LLP

Position in OGN — Organon & Co.

CIK 1318757 LONDON, X0

Position in OGN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$11,212,919

+$5,623,195 QoQ

Shares Held

828,133

-11.3% QoQ

Ownership

0.315%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#45

of 626 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $2,303,425,127 across 13 Drug Manufacturers - General names. OGN ranks #10 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,989,537	$759,252,709
2	ABBV	AbbVie Inc.	2,990,512	$752,532,439
3	LLY	ELI LILLY & Co	334,637	$401,373,688
4	AZN	Astrazeneca PLC	841,164	$159,501,517
5	NVO	Novo Nordisk A S	1,707,104	$81,838,564
6	NVS	Novartis AG	330,061	$51,727,159
7	AMGN	Amgen Inc	99,402	$35,995,452
8	GILD	Gilead Sciences, Inc.	204,677	$25,858,892

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,212,919	828,133	-11.3%	Shares	Other	2026-08-13
2026-03-31	$5,589,724	933,176	+112.1%	Shares	Other	2026-05-15
2025-12-31	$3,154,563	439,967	+487.9%	Shares	Other	2026-02-13
2025-09-30	$799,323	74,843	-5.5%	Shares	Other	2025-11-13
2025-06-30	$766,481	79,182	+173.3%	Shares	Other	2025-08-13
2024-12-31	$432,306	28,975	-48.7%	Shares	Other	2025-02-13
2024-09-30	$1,080,366	56,475	-66.5%	Shares	Other	2024-11-14
2023-12-31	$2,428,400	168,405	-59.2%	Shares	Other	2024-02-14
2023-09-30	$7,165,929	412,784	+248.6%	Shares	Other	2023-11-14
2023-03-31	$2,784,885	118,405	+987.9%	Shares	Other	2023-05-15
2022-09-30	$254,685	10,884	+15016.7%	Shares	Other	2022-11-14
2021-12-31	$2,192	72	—	Shares	Other	2022-02-14
No filing history on record for this holder in this stock.